STAT+: Pharmalittle: Will the Supreme Court review controversial patent rulings? GSK prepares for its consumer health spinoff
In the coming weeks, the U.S. Supreme Court is expected to decide whether to review a debate over patents that has the pharmaceutical industry on edge.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about
